Table 2. Baseline characteristics of patients infected with COVID-2019.
| Baseline variables | Total(n=93) | non-sever (n=69) | Severe (including critical illness)(n=24) | P-Value |
| Wuhan exposure(%) | 29 (31.1) | 21 (30.4) | 9 (37.5) | 0.524 |
| co morbidities (%) | 50 (53.7) | 29 (42.1) | 21 (87.5) | <0.01 |
| Diabetes | 21 (22.5) | 8 (11.6) | 13 (54.2) | <0.01 |
| Hypertension | 23 (24.7) | 7 (10.1) | 16 (66.8) | <0.01 |
| hepatitis B | 11 (11.8) | 7 (10.1) | 4 (16.7) | 0.409 |
| Heart disease | 13 (13.9) | 4 (5.8) | 9 (37.5) | <0.01 |
| Renal dysfunction | 10(10.7) | 2 (2.9) | 8 (33.3) | <0.05 |
| Abnormal liver function | 13 (13.9) | 9 (13.0) | 4 (16.7) | 0.659 |
| others | 5 5.4) | 3 (4.3) | 2 (8.3) | 0.456 |
| Signs and symptoms | ||||
| Fever | 72 (77.4) | 55 (79.7) | 17 (70.8) | 0.37 |
| Chill | 22 (23.6) | 12 (17.4) | 10 (41.6) | <0.05 |
| Shivering | 11 (11.8) | 5 (7.2) | 6 (25) | <0.05 |
| Fatigue | 60 (64.5) | 42 (60.8) | 18 (75) | 0.213 |
| Cough | 67 (72.1) | 51 (73.9) | 16 (66.7) | 0.496 |
| Sputum production | 44 (47.3) | 25 (36.2) | 19 (79.1) | <0.01 |
| Pharyngalgia | 10 (10.7) | 7 (10.1) | 3 (12.5) | 0.748 |
| Dizziness | 17 (18.3) | 10 (14.5) | 7 (29.1) | 0.109 |
| Headache | 18 (19.3) | 13 (18.8) | 5 (20.8) | 0.831 |
| Chest tightness | 28 (30.1) | 17 (24.6) | 11 (45.8) | 0.051 |
| Chest pain | 6 (6.5) | 3 (4.4) | 2 (8.3) | 0.456 |
| Shortness of breath | 5 (5.4) | 2 (2.9) | 3 (12.5) | 0.072 |
| Nausea | 10 (10.7) | 4 (5.8) | 6 (25) | <0.01 |
| Diarrhoea | 1 (1.1) | 1 (1.5) | 0 | 0.999 |
| Vomiting | 3 (4.3) | 2 (2.9) | 1 (4.2) | 0.762 |